…tokine release syndrome (CRS) is a life-threatening toxicity of chimeric antigen receptor T-cell therapy (CART) for B-cell acute lymphoblastic leukemia (B-ALL). Lower r…
3articles mentioning treatments
3treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: chimeric antigen receptor T-cell therapy ×
chimeric antigen receptor T-cell therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning chimeric antigen receptor T-cell therapy
3 articles · page 1 of 1chimeric antigen receptor T-cell therapyCD19-directed CARTB-cell acute lymphoblastic leukemia (B-ALL)Cytokine release syndromeCART22
chimeric antigen receptor T-cell therapyhaematological malignanciesvoriconazolerefractory diffuse large B-cell lymphomaazole
…er 50s with refractory diffuse large B-cell lymphoma undergoing chimeric antigen receptor T-cell therapy. On day 8 post-infusion, she developed hypoxia, haemodynamic in…
chimeric antigen receptor T-cell therapyCARTlarge B-cell lymphoma (LBCL)axicabtagene ciloleucelPGS Catalog
…omes in patients with large B-cell lymphoma (LBCL) treated with chimeric antigen receptor T-cell therapy (CART). However, a comprehensive analysis of germline determina…